Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts

Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies

Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Date Posted: Thursday, December 08, 2011
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

KINAXO and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
KINAXO will apply its PhosphoScout® for the identification of novel biomarkers in a clinical trial conducted by Bayer Vital.
Thursday, October 29, 2009
KINAXO Biotechnologies and Bayer Vital Collaborate in Phosphoproteomics Biomarker Identification
KINAXO will apply its PhosphoScout® for the identification of biomarkers in a clinical trial conducted by Bayer Vital.
Monday, October 19, 2009
Kinaxo Contributes its Quantitative Phosphoproteomics Platform to a Drug Efficiency Study
Company receives a grant by the Bavarian Research Foundation to expand applications for its quantitative phosphoproteomics platform.
Thursday, February 26, 2009
Scientific News
Scientists Create Synthetic Membranes That Grow Like Living Cells
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.
Metabolite of Cancer Drug More Effective at Treating Aggressive Tumors
Researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, has more anti-cancer properties than its precursor.
Giant Panda Microbiome Poorly Adapted for a Bamboo Diet
Researchers have found that the microbiome of the Giant Panda lacks key bacterial species typically found in herbivores.
Infant Antibiotic use Linked to Adult Diseases
A new study has found a three-way link among antibiotic use in infants, changes in the gut bacteria and disease later in life.
Potential Forensic Uses for Human Microbiome
A recent study suggests microbial communities found on or in some sites in an individual's body can be used as fingerprint-like identifiers.
Ease of Weight Loss Influenced by Individual Biology
NIH study finds varied responses to calorie restriction in obese adults.
LECO Announces Special Events at ASMS
Company to host a series of events during the conference held at the America’s Center, Saint Louis, MO on May 31-June 4.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters